Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Factor vii deficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 51 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Factor vii deficiency.

Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN

Side Effect Reports % Deaths Hosp.
Off label use 169 17.8% 85 50
Haemorrhage 129 13.6% 21 53
Drug ineffective 117 12.3% 26 47
Death 85 8.9% 85 8
Pre-existing disease 78 8.2% 78 22
Therapy partial responder 78 8.2% 76 23
Acquired haemophilia 72 7.6% 70 23
Haemarthrosis 47 4.9% 3 27
Haematoma 30 3.2% 3 21
Therapy responder 30 3.2% 27 22
Thrombosis 27 2.8% 6 12
Condition aggravated 23 2.4% 8 11
Shock haemorrhagic 20 2.1% 14 8
Epistaxis 19 2.0% 0 13
Haemorrhage intracranial 19 2.0% 7 8

Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN

Acquired haemophilia (244) Factor viii deficiency (130) Product used for unknown indication (97) Haemorrhage (92) Prophylaxis (54) Haemophilia (44) Haemophilia a with anti factor viii (43) Factor ix deficiency (36) Haemostasis (30) Off label use (26)

Other Drugs Used for Factor vii deficiency

EMICIZUMAB-KXWH (94) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (24)

Related Pages

COAGULATION FACTOR VIIA RECOMBINANT HUMAN Full Profile All Factor vii deficiency Drugs COAGULATION FACTOR VIIA RECOMBINANT HUMAN Demographics COAGULATION FACTOR VIIA RECOMBINANT HUMAN Timeline